Log In
Print
BCIQ
Print
Print this Print this
 

Yisaipu, biosimilar etanercept

  Manage Alerts
Collapse Summary General Information
Company Shanghai CP Guojian Pharmaceutical Co. Ltd.
DescriptionBiosimilar version of Enbrel etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today